Yuyu Pharma, Inc. Logo

Yuyu Pharma, Inc.

Develops, manufactures, and markets pharmaceuticals, focusing on CNS disorders.

000220 | KO

Overview

Corporate Details

ISIN(s):
KR7000220004
LEI:
Country:
South Korea
Address:
충청북도 제천시 바이오밸리1로 94, 제천시

Description

Yuyu Pharma, Inc., established in 1941, is a healthcare company focused on the development, manufacturing, and marketing of pharmaceutical products. The company is committed to creating innovative therapeutics to address healthcare challenges and improve quality of life. Its research and development efforts are concentrated on key therapeutic areas, with a notable emphasis on treatments for central nervous system disorders, including Alzheimer's disease. The company operates through several divisions, including Yuyu Healthcare, which provides pharmaceutical-standard Original Design Manufacturer (ODM) and Original Equipment Manufacturer (OEM) services.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-28 00:00
주식등의대량보유상황보고서(일반)
Korean 116.4 KB
2025-08-13 00:00
반기보고서 (2025.06)
Korean 1.5 MB
2025-07-22 00:00
주식등의대량보유상황보고서(일반)
Korean 123.1 KB
2025-07-22 00:00
최대주주등소유주식변동신고서
Korean 52.2 KB
2025-07-15 00:00
자기주식취득결과보고서
Korean 67.0 KB
2025-07-01 00:00
주식등의대량보유상황보고서(일반)
Korean 117.4 KB
2025-05-29 00:00
주식등의대량보유상황보고서(약식)
Korean 67.6 KB
2025-05-22 00:00
전환가액ㆍ신주인수권행사가액ㆍ교환가액의조정(안내공시)
Korean 12.6 KB
2025-05-15 00:00
분기보고서 (2025.03)
Korean 1.4 MB
2025-04-22 00:00
주요사항보고서(자기전환사채만기전취득결정)
Korean 14.7 KB
2025-04-15 00:00
주요사항보고서(자기전환사채만기전취득결정)
Korean 24.0 KB
2025-04-15 00:00
기타경영사항(자율공시)
Korean 5.9 KB
2025-04-11 00:00
주요사항보고서(자기주식취득결정)
Korean 32.8 KB
2025-03-27 00:00
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 14.0 KB
2025-03-27 00:00
정기주주총회결과
Korean 32.9 KB

Automate Your Workflow. Get a real-time feed of all Yuyu Pharma, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Yuyu Pharma, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Yuyu Pharma, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.